Alignment Healthcare, Inc. is classed by the SEC under Hospital & Medical Service Plans (industry code 6324), based in Orange, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $3.9 billion and a loss of $978 thousand (its filed statements).
Insurance businessHospital & Medical Service PlansOrange, CAfilings since 20209 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a insurance business: prior from its industry code (SEC 6324, Hospital & Medical Service Plans); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.1 out of ten, 9 of 9 metrics filed: past 4.1 out of ten, present 4.1 out of ten, future 7.9 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 6.5 out of ten. No warning events in its filings since 2020. 65th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 5.9 out of ten. +31.7% a year over 7 filed years; profitable in 0 of 7. 59th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 1.6 out of ten. Share count grew 3.0% a year. 0% of cash flow returned. Insiders: 83 sales, 1 purchases. 16th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 2.2 out of ten. ROE 0%: lost 0¢ per shareholder dollar. Leverage 83%: owes 83¢ per asset dollar. 22nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 4.8 out of ten. bottom 48% of 10 in its family; net margin 0%. 48th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 6.9 out of ten. top 31% of 10 in its family for leadership; chief executive since 2021. 69th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 7.0 out of ten. top 30% of 10 in its family for room to expand. 70th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 8.5 out of ten. top 15% of 10 in its family for growth drivers. 85th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 8.2 out of ten. top 18% of 10 in its family for expectations against reality. 82nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-27 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-30 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-30 (on EDGAR). Newest filing: Form 8-K, 2026-10-08. Filings on record since 2020. Read from EDGAR 2026-10-12.
Who runs it
Kao, John E (Chief Executive Officer); Maroney, Dawn Christine (President); Kent, Mark D. (President - MSO); Head, James M (Chief Financial Officer); Burzacchi, Sebastian (COO - Mgmt Services Org); Kim, Hyong (Chief Medical Officer); Hochradel, Shane J. (Chief Operations Officer); Joyce, Christopher J (Chief Legal and Admin. Officer); Scavo, Robert L. (Chief Information Officer); Wagner, Andreas P. (Chief Human Resources Officer); and 20 more. 30 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-07.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.